Fatigue Countermeasure Program in Operational Flight Controllers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to validate the acceptability, operational feasibility and efficacy of a combined fatigue countermeasure comprised of shorter-wavelength light and exercise during operational Orbit 1 night shifts to improve alertness and performance of flight mission controllers.
Specifically, the investigators will:
- Feasibility. Test the feasibility of developing a break room containing fatigue countermeasures (shorter-wavelength light and exercise equipment) to be used by flight mission controllers during Orbit 1 night shifts, and the feasibility to schedule regular breaks during the Orbit 1 shift so that flight mission controllers have the opportunity to use the fatigue countermeasures break room.
- Acceptability. Test the acceptability of the use of the fatigue countermeasures break room evaluating when and how the room is used by flight mission controllers, as measured on End-of-Shift Productivity Questionnaire.
- Test the hypothesis that alertness and performance will be impaired in flight mission controllers during Orbit 1 operational night shifts as compared to flight mission controllers working a non-console day shift.
- Test the hypothesis that alertness and performance of flight mission controllers who exercise and are exposed to shorter wavelength light during the Orbit 1 night shift will be significantly more alert and have better mood, performance (e.g., less PVT lapses, increased productivity) than those same mission controllers working Orbit 1 night shifts without exposure to the shorter wavelength light and exercise.
- Test the acceptability, operational feasibility and efficacy of implementing an anonymous sleep disorders screening for flight controllers, evaluated by number of visitors to the screening web site and the number of completed assessments.
| Condition | Intervention |
|---|---|
|
Fatigue |
Behavioral: blue-wavelength enriched ceiling light Behavioral: mild exercise |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | Experimental Trial of Fatigue Countermeasure Program in Operational Flight Controllers |
- Alertness/Fatigue as measured by Psychomotor Vigilance Task and Visual Analog Scales [ Time Frame: Three weeks. ] [ Designated as safety issue: No ]
- Sleep duration as measured by wrist actigraphy [ Time Frame: Three weeks. ] [ Designated as safety issue: No ]
- Sleep duration as captured in sleep/work logs [ Time Frame: Three weeks. ] [ Designated as safety issue: No ]
| Enrollment: | 20 |
| Study Start Date: | September 2012 |
| Study Completion Date: | November 2012 |
| Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Access to experimental break room
Subjects will visit the experimental break room 4 times per Orbit 1 shift:
In the break room, subjects will be passively exposed to blue-wavelength enriched ceiling lights during all four visits for each work shift. Also in the break room, subjects will perform 10-minutes of mild exercise during the first three visits to the break room during each work shift. |
Behavioral: blue-wavelength enriched ceiling light
Subjects will be in the experimental break room for four 20-minute periods for each Orbit 1 work shift.
Other Name: Sylvania Fluorescent Octron FO32/SKYWHITE/XP/ECO 8000K
Behavioral: mild exercise
Subjects will be asked to achieve 65% of maximum heart rate on either a treadmill or exercise cycle for 10-minutes, three times during each Orbit 1 work shift.
Other Names:
|
Detailed Description:
Each participant will have three data collection periods. Each data collection period will last one shift rotation (5 -7 days): One 5-shift or 7-shift block of Orbit 1 night shifts on console with access to photic and exercise countermeasures, a second 5-shift or 7-shift block of Orbit 1 night shifts on console with no access to countermeasures, and a third 5-shift block of daytime office work off console. We will be measuring sleep via a wrist worn activity measuring device and compliance of exercise intervention via a small, commercially available heart monitor worn around the chest underneath clothing. The activity device will be worn continuously and the heart monitor will be worn on shift. These devices will be downloaded at the end of each block of shifts. Subjects will complete a short baseline questionnaire once at the beginning of the study. Subjective alertness will be assessed with the Karolinska Sleepiness Scale (KSS), performance testing will occur regularly and 'end of shift' questionnaires will be completed at the end of each shift. Drowsiness will be measured on the commute to and from work with the Optalert.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Must be current Johnson Space Center International Space Station Flight Controller or Flight Director cleared to sit console for Orbit 1 work shift
- Work schedule must meet both study needs and NASA scheduling operational constraints
Exclusion Criteria:
- none
Contacts and Locations| United States, Texas | |
| Johnson Space Center | |
| Houston, Texas, United States, 77058 | |
| Principal Investigator: | Charles A Czeisler, PhD, MD | Brigham and Women's Hospital / Harvard Medical School |
| Study Director: | Laura K Barger, PhD | Brigham and Women's Hospital / Harvard Medical School |
More Information
No publications provided
| Responsible Party: | Charles Andrew Czeisler, MD, PhD, Chief, Division of Sleep Medicine, Brigham and Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT01744678 History of Changes |
| Other Study ID Numbers: | NNX10AF47G |
| Study First Received: | October 11, 2012 |
| Last Updated: | December 5, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Fatigue Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013